Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.39409674 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.44781323 |
3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.39058386 |
4 | negative T cell selection (GO:0043383) | 6.09736400 |
5 | negative thymic T cell selection (GO:0045060) | 5.95807868 |
6 | pinocytosis (GO:0006907) | 5.92191497 |
7 | ATP synthesis coupled proton transport (GO:0015986) | 5.88914404 |
8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.88914404 |
9 | regulation of phospholipase A2 activity (GO:0032429) | 5.87987369 |
10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78291062 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78291062 |
12 | positive thymic T cell selection (GO:0045059) | 5.53681287 |
13 | interferon-gamma production (GO:0032609) | 5.48398430 |
14 | intracellular pH reduction (GO:0051452) | 5.42225007 |
15 | protein complex biogenesis (GO:0070271) | 5.38944119 |
16 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.31568905 |
17 | thymic T cell selection (GO:0045061) | 5.30507362 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.26056704 |
19 | protein neddylation (GO:0045116) | 5.25332323 |
20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.23552347 |
21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.23552347 |
22 | NADH dehydrogenase complex assembly (GO:0010257) | 5.23552347 |
23 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.22158451 |
24 | chaperone-mediated protein transport (GO:0072321) | 5.14794397 |
25 | regulation of T cell tolerance induction (GO:0002664) | 5.11208222 |
26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10545889 |
27 | modulation by symbiont of host immune response (GO:0052553) | 5.10545889 |
28 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10545889 |
29 | modulation by symbiont of host defense response (GO:0052031) | 5.10545889 |
30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10545889 |
31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10545889 |
32 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.06344904 |
33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.00471547 |
34 | positive T cell selection (GO:0043368) | 4.99970865 |
35 | membrane raft organization (GO:0031579) | 4.96167829 |
36 | thrombin receptor signaling pathway (GO:0070493) | 4.93841578 |
37 | respiratory electron transport chain (GO:0022904) | 4.92708874 |
38 | electron transport chain (GO:0022900) | 4.84515958 |
39 | sphingolipid catabolic process (GO:0030149) | 4.80387182 |
40 | T cell selection (GO:0045058) | 4.78034649 |
41 | T cell migration (GO:0072678) | 4.76685640 |
42 | positive regulation of megakaryocyte differentiation (GO:0045654) | 4.76377708 |
43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.73925475 |
44 | ribosomal small subunit assembly (GO:0000028) | 4.72510378 |
45 | glycosphingolipid catabolic process (GO:0046479) | 4.71873940 |
46 | tolerance induction (GO:0002507) | 4.64225773 |
47 | viral transcription (GO:0019083) | 4.56440037 |
48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.50326016 |
49 | translational termination (GO:0006415) | 4.48743740 |
50 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 4.43486781 |
51 | leukocyte aggregation (GO:0070486) | 4.41780108 |
52 | cellular response to exogenous dsRNA (GO:0071360) | 4.39145373 |
53 | membrane lipid catabolic process (GO:0046466) | 4.35372832 |
54 | pH reduction (GO:0045851) | 4.28894539 |
55 | proteasome assembly (GO:0043248) | 4.27179823 |
56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.26948391 |
57 | negative regulation of cell killing (GO:0031342) | 4.25351277 |
58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25351277 |
59 | termination of RNA polymerase III transcription (GO:0006386) | 4.23591424 |
60 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.23591424 |
61 | cotranslational protein targeting to membrane (GO:0006613) | 4.22133301 |
62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.21926686 |
63 | T cell costimulation (GO:0031295) | 4.21072369 |
64 | glycolipid catabolic process (GO:0019377) | 4.20991471 |
65 | mast cell activation (GO:0045576) | 4.18971254 |
66 | protein targeting to ER (GO:0045047) | 4.15166136 |
67 | lymphocyte costimulation (GO:0031294) | 4.14098648 |
68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12156796 |
69 | respiratory chain complex IV assembly (GO:0008535) | 4.10865354 |
70 | microglial cell activation (GO:0001774) | 4.07457042 |
71 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 4.06352606 |
72 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.96482404 |
73 | chromatin remodeling at centromere (GO:0031055) | 3.95324494 |
74 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.95159958 |
75 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.94213261 |
76 | ceramide catabolic process (GO:0046514) | 3.93314698 |
77 | protein localization to endoplasmic reticulum (GO:0070972) | 3.92719334 |
78 | maturation of SSU-rRNA (GO:0030490) | 3.92413692 |
79 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.90653460 |
80 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.90653460 |
81 | CENP-A containing nucleosome assembly (GO:0034080) | 3.87506692 |
82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86721403 |
83 | T cell receptor signaling pathway (GO:0050852) | 3.86274304 |
84 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.83488180 |
85 | positive regulation of antigen processing and presentation (GO:0002579) | 3.79902667 |
86 | translational elongation (GO:0006414) | 3.77657402 |
87 | cytochrome complex assembly (GO:0017004) | 3.76380213 |
88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.76354273 |
89 | regulation of lymphocyte migration (GO:2000401) | 3.70541907 |
90 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.69662632 |
91 | actin nucleation (GO:0045010) | 3.68245915 |
92 | regulation of tolerance induction (GO:0002643) | 3.66592286 |
93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65159738 |
94 | cellular extravasation (GO:0045123) | 3.63406562 |
95 | cellular response to interferon-beta (GO:0035458) | 3.63176646 |
96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61075198 |
97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.59316197 |
98 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.59290677 |
99 | positive regulation of tolerance induction (GO:0002645) | 3.58027191 |
100 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57326984 |
101 | ribosomal large subunit biogenesis (GO:0042273) | 3.55812166 |
102 | positive regulation of interferon-alpha production (GO:0032727) | 3.54993004 |
103 | negative regulation of osteoclast differentiation (GO:0045671) | 3.54008881 |
104 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.53935870 |
105 | cellular response to interleukin-15 (GO:0071350) | 3.52086542 |
106 | platelet dense granule organization (GO:0060155) | 3.51836092 |
107 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.51323529 |
108 | DNA deamination (GO:0045006) | 3.46777112 |
109 | regulation of interferon-alpha production (GO:0032647) | 3.46250651 |
110 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.45168364 |
111 | hydrogen ion transmembrane transport (GO:1902600) | 3.43197797 |
112 | translation (GO:0006412) | 3.42824314 |
113 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.42488425 |
114 | negative regulation of ligase activity (GO:0051352) | 3.42488425 |
115 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.41933343 |
116 | regulation of antigen processing and presentation (GO:0002577) | 3.40979381 |
117 | ribosomal small subunit biogenesis (GO:0042274) | 3.40009017 |
118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.39141050 |
119 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.39014450 |
120 | viral life cycle (GO:0019058) | 3.38718912 |
121 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.37406726 |
122 | inner mitochondrial membrane organization (GO:0007007) | 3.36537923 |
123 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.36276721 |
124 | cellular protein complex disassembly (GO:0043624) | 3.35730406 |
125 | regulation of mitochondrial translation (GO:0070129) | 3.32430225 |
126 | regulation of B cell differentiation (GO:0045577) | 3.30265666 |
127 | megakaryocyte development (GO:0035855) | 3.30062872 |
128 | response to interleukin-15 (GO:0070672) | 3.29770984 |
129 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29660535 |
130 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.29265003 |
131 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.27991372 |
132 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.26799673 |
133 | base-excision repair, AP site formation (GO:0006285) | 3.26296750 |
134 | cullin deneddylation (GO:0010388) | 3.24998016 |
135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.24492474 |
136 | translational initiation (GO:0006413) | 3.23919332 |
137 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23817517 |
138 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.22205241 |
139 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.22205241 |
140 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.22205241 |
141 | ATP biosynthetic process (GO:0006754) | 3.21961875 |
142 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.21564856 |
143 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21274509 |
144 | rRNA modification (GO:0000154) | 3.20038250 |
145 | negative regulation of B cell proliferation (GO:0030889) | 3.19057946 |
146 | protein deneddylation (GO:0000338) | 3.18795276 |
147 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.17716566 |
148 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.17716566 |
149 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.17697509 |
150 | protein-cofactor linkage (GO:0018065) | 3.14370409 |
151 | chemokine-mediated signaling pathway (GO:0070098) | 3.13555060 |
152 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.13132910 |
153 | protein targeting to mitochondrion (GO:0006626) | 3.12741415 |
154 | proton transport (GO:0015992) | 3.11954176 |
155 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.11535316 |
156 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.11535316 |
157 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10042555 |
158 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.09983221 |
159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08727118 |
160 | pseudouridine synthesis (GO:0001522) | 3.08206234 |
161 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.07389055 |
162 | positive regulation of interleukin-2 production (GO:0032743) | 3.07054794 |
163 | release of sequestered calcium ion into cytosol (GO:0051209) | 3.06996022 |
164 | negative regulation of sequestering of calcium ion (GO:0051283) | 3.06996022 |
165 | hydrogen transport (GO:0006818) | 3.05651710 |
166 | oligosaccharide catabolic process (GO:0009313) | 3.05558308 |
167 | cellular component biogenesis (GO:0044085) | 3.05409061 |
168 | response to host immune response (GO:0052572) | 3.05368880 |
169 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05368880 |
170 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.05243886 |
171 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.05243886 |
172 | sequestering of actin monomers (GO:0042989) | 3.04236601 |
173 | grooming behavior (GO:0007625) | 3.03906250 |
174 | positive regulation of interferon-gamma production (GO:0032729) | 3.03768375 |
175 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.03657760 |
176 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02739765 |
177 | histone exchange (GO:0043486) | 3.02600934 |
178 | mannosylation (GO:0097502) | 3.02199225 |
179 | spliceosomal snRNP assembly (GO:0000387) | 3.02145423 |
180 | immunoglobulin mediated immune response (GO:0016064) | 3.01861962 |
181 | establishment of protein localization to mitochondrion (GO:0072655) | 3.01149254 |
182 | protein localization to mitochondrion (GO:0070585) | 3.00507952 |
183 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.00452088 |
184 | negative regulation of type 2 immune response (GO:0002829) | 2.99331224 |
185 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.98426935 |
186 | respiratory burst (GO:0045730) | 2.96491841 |
187 | intracellular protein transmembrane import (GO:0044743) | 2.96254195 |
188 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.95267027 |
189 | oxidative phosphorylation (GO:0006119) | 2.91394512 |
190 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.91294493 |
191 | deoxyribonucleotide catabolic process (GO:0009264) | 2.91159827 |
192 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.90831548 |
193 | DNA double-strand break processing (GO:0000729) | 2.90048145 |
194 | positive regulation of ligase activity (GO:0051351) | 2.86675799 |
195 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.86410915 |
196 | histone mRNA metabolic process (GO:0008334) | 2.81850587 |
197 | deoxyribose phosphate catabolic process (GO:0046386) | 2.81787497 |
198 | peptidyl-histidine modification (GO:0018202) | 2.79742000 |
199 | replication fork processing (GO:0031297) | 2.74266963 |
200 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.73643805 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.78382545 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.41016319 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.16062627 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.12137631 |
5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.83725525 |
6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.45015549 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.40207878 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.37757523 |
9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.03436587 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73667548 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.72058613 |
12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.61170858 |
13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.59461614 |
14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.43116856 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38963608 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.26596717 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25375421 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.25063224 |
19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24138872 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 3.13670112 |
21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.04730712 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.01115062 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99593225 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.99161511 |
25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.95556263 |
26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.95530497 |
27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.88524587 |
28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.87627879 |
29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86002608 |
30 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.80562900 |
31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.73420928 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 2.63042346 |
33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.62458402 |
34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57229041 |
35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.53005996 |
36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52373824 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 2.47532416 |
38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41787355 |
39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29419057 |
40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23848465 |
41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.20854007 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.16649203 |
43 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16522824 |
44 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.13545336 |
45 | VDR_22108803_ChIP-Seq_LS180_Human | 2.09913215 |
46 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05283577 |
47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02749502 |
48 | MYC_22102868_ChIP-Seq_BL_Human | 2.01101032 |
49 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00387103 |
50 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.99369069 |
51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95662518 |
52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.93235359 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92747539 |
54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89416358 |
55 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88526601 |
56 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88426668 |
57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.86828909 |
58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86400437 |
59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83809877 |
60 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82186556 |
61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79193814 |
62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78037660 |
63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.77519429 |
64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74896720 |
65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73636846 |
66 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.73496873 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72321222 |
68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72262753 |
69 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.71507850 |
70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69682280 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.67593448 |
72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66268646 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66029865 |
74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.62219830 |
75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61083762 |
76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60862686 |
77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.60009174 |
78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57146256 |
79 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.56364591 |
80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48541651 |
81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47762250 |
82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42922020 |
83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42461524 |
84 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40317545 |
85 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.38257960 |
86 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.36494357 |
87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32897457 |
88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31768296 |
89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30989397 |
90 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30756805 |
91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.30668911 |
92 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29669239 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28835163 |
94 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.28823874 |
95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28101381 |
96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27998728 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27792857 |
98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27688283 |
99 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23381057 |
100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22522427 |
101 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20565251 |
102 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20427942 |
103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20329333 |
104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20215779 |
105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19448750 |
106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18521702 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17711526 |
108 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17334925 |
109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17150960 |
110 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16946179 |
111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16378692 |
112 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15809384 |
113 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15086157 |
114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13831356 |
115 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13028290 |
116 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13025479 |
117 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09821399 |
118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09671277 |
119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09066905 |
120 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07046496 |
121 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06485666 |
122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06285604 |
123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05293026 |
124 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05154084 |
125 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04838801 |
126 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04367232 |
127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03430605 |
128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03184424 |
129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03122066 |
130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02990024 |
131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02304762 |
132 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00808229 |
133 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00808229 |
134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99921770 |
135 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99381575 |
136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99243421 |
137 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98999483 |
138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98652151 |
139 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.95814108 |
140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95670194 |
141 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94340824 |
142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93116077 |
143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93034776 |
144 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92666747 |
145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90632763 |
146 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90227958 |
147 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89825704 |
148 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89680494 |
149 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89035059 |
150 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88617122 |
151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88607339 |
152 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88402411 |
153 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86760643 |
154 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86043232 |
155 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86043232 |
156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85383273 |
157 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.85204883 |
158 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84394481 |
159 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83958823 |
160 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83891173 |
161 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83651296 |
162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.83123878 |
163 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82805922 |
164 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82710165 |
165 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.82486463 |
166 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82312050 |
167 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81285906 |
168 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.81129982 |
169 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.81022949 |
170 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80513184 |
171 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80207260 |
172 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.79716541 |
173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75738651 |
174 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75056246 |
175 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74369268 |
176 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73997628 |
177 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72715030 |
178 | GATA1_22025678_ChIP-Seq_K562_Human | 0.71888955 |
179 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.71869241 |
180 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69664172 |
181 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69282941 |
182 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68246712 |
183 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67167421 |
184 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66201782 |
185 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.65431482 |
186 | * P300_27268052_Chip-Seq_Bcells_Human | 0.61843122 |
187 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61649273 |
188 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.61127343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 6.19536904 |
2 | MP0005671_abnormal_response_to | 4.95726700 |
3 | MP0006082_CNS_inflammation | 4.37410587 |
4 | MP0009379_abnormal_foot_pigmentation | 3.58441789 |
5 | MP0003763_abnormal_thymus_physiology | 3.51064922 |
6 | MP0006292_abnormal_olfactory_placode | 3.12056620 |
7 | MP0005387_immune_system_phenotype | 3.06515519 |
8 | MP0001790_abnormal_immune_system | 3.06515519 |
9 | MP0000685_abnormal_immune_system | 3.05072755 |
10 | MP0002166_altered_tumor_susceptibility | 2.95492490 |
11 | MP0008058_abnormal_DNA_repair | 2.93995875 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.89623249 |
13 | MP0001800_abnormal_humoral_immune | 2.89605824 |
14 | MP0000372_irregular_coat_pigmentation | 2.84307224 |
15 | MP0001819_abnormal_immune_cell | 2.82554346 |
16 | MP0003136_yellow_coat_color | 2.79986907 |
17 | MP0009333_abnormal_splenocyte_physiolog | 2.78067411 |
18 | MP0002452_abnormal_antigen_presenting | 2.77932397 |
19 | MP0005000_abnormal_immune_tolerance | 2.71947010 |
20 | MP0002006_tumorigenesis | 2.70362158 |
21 | MP0009785_altered_susceptibility_to | 2.68379845 |
22 | MP0002420_abnormal_adaptive_immunity | 2.67389979 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.62978714 |
24 | MP0002723_abnormal_immune_serum | 2.58223597 |
25 | MP0002102_abnormal_ear_morphology | 2.55914306 |
26 | MP0005025_abnormal_response_to | 2.53633942 |
27 | MP0010094_abnormal_chromosome_stability | 2.45191901 |
28 | MP0003186_abnormal_redox_activity | 2.38450542 |
29 | MP0002398_abnormal_bone_marrow | 2.35109840 |
30 | MP0002405_respiratory_system_inflammati | 2.34942998 |
31 | MP0003436_decreased_susceptibility_to | 2.33315677 |
32 | MP0003693_abnormal_embryo_hatching | 2.32296476 |
33 | MP0004510_myositis | 2.25028220 |
34 | MP0003718_maternal_effect | 2.19729281 |
35 | MP0005464_abnormal_platelet_physiology | 2.18144573 |
36 | MP0006036_abnormal_mitochondrial_physio | 2.16423076 |
37 | MP0002419_abnormal_innate_immunity | 2.13878375 |
38 | * MP0000716_abnormal_immune_system | 2.08586732 |
39 | MP0001853_heart_inflammation | 2.08506395 |
40 | MP0002938_white_spotting | 2.06304151 |
41 | MP0004147_increased_porphyrin_level | 2.02606697 |
42 | MP0008789_abnormal_olfactory_epithelium | 2.02161739 |
43 | MP0001529_abnormal_vocalization | 1.98578670 |
44 | MP0010155_abnormal_intestine_physiology | 1.96802942 |
45 | MP0005084_abnormal_gallbladder_morpholo | 1.95395411 |
46 | MP0006072_abnormal_retinal_apoptosis | 1.91646134 |
47 | MP0002653_abnormal_ependyma_morphology | 1.89903172 |
48 | MP0002722_abnormal_immune_system | 1.87755761 |
49 | MP0000689_abnormal_spleen_morphology | 1.86889582 |
50 | MP0005410_abnormal_fertilization | 1.86162636 |
51 | MP0003300_gastrointestinal_ulcer | 1.85111283 |
52 | MP0003011_delayed_dark_adaptation | 1.82915834 |
53 | MP0003866_abnormal_defecation | 1.82434289 |
54 | MP0000703_abnormal_thymus_morphology | 1.80892967 |
55 | MP0002277_abnormal_respiratory_mucosa | 1.80422166 |
56 | MP0002638_abnormal_pupillary_reflex | 1.79928781 |
57 | MP0006035_abnormal_mitochondrial_morpho | 1.78698167 |
58 | MP0001485_abnormal_pinna_reflex | 1.76363845 |
59 | MP0002736_abnormal_nociception_after | 1.76363388 |
60 | MP0004947_skin_inflammation | 1.76250991 |
61 | MP0002095_abnormal_skin_pigmentation | 1.70739128 |
62 | MP0003786_premature_aging | 1.68590236 |
63 | * MP0002429_abnormal_blood_cell | 1.67141787 |
64 | MP0004142_abnormal_muscle_tone | 1.67043990 |
65 | MP0001873_stomach_inflammation | 1.62168300 |
66 | MP0005310_abnormal_salivary_gland | 1.61016908 |
67 | MP0001845_abnormal_inflammatory_respons | 1.57772510 |
68 | MP0003724_increased_susceptibility_to | 1.55941483 |
69 | MP0001293_anophthalmia | 1.54747628 |
70 | MP0000569_abnormal_digit_pigmentation | 1.52374599 |
71 | MP0005551_abnormal_eye_electrophysiolog | 1.44444895 |
72 | MP0003077_abnormal_cell_cycle | 1.44428948 |
73 | MP0002163_abnormal_gland_morphology | 1.42556564 |
74 | MP0004957_abnormal_blastocyst_morpholog | 1.42437867 |
75 | MP0002160_abnormal_reproductive_system | 1.36164891 |
76 | MP0005253_abnormal_eye_physiology | 1.34560853 |
77 | MP0000858_altered_metastatic_potential | 1.33438886 |
78 | MP0008932_abnormal_embryonic_tissue | 1.31868573 |
79 | MP0005499_abnormal_olfactory_system | 1.31118096 |
80 | MP0005394_taste/olfaction_phenotype | 1.31118096 |
81 | MP0001968_abnormal_touch/_nociception | 1.29819196 |
82 | MP0002234_abnormal_pharynx_morphology | 1.29149856 |
83 | MP0002396_abnormal_hematopoietic_system | 1.28137805 |
84 | MP0003880_abnormal_central_pattern | 1.24771359 |
85 | MP0003195_calcinosis | 1.24198719 |
86 | MP0005389_reproductive_system_phenotype | 1.22752337 |
87 | MP0005379_endocrine/exocrine_gland_phen | 1.19905671 |
88 | MP0000490_abnormal_crypts_of | 1.19337118 |
89 | MP0004808_abnormal_hematopoietic_stem | 1.18507329 |
90 | MP0005075_abnormal_melanosome_morpholog | 1.17487443 |
91 | MP0000343_altered_response_to | 1.17436253 |
92 | MP0001905_abnormal_dopamine_level | 1.15485582 |
93 | MP0003448_altered_tumor_morphology | 1.14489091 |
94 | MP0009697_abnormal_copulation | 1.14235230 |
95 | MP0003111_abnormal_nucleus_morphology | 1.14071489 |
96 | MP0001984_abnormal_olfaction | 1.13607337 |
97 | MP0003566_abnormal_cell_adhesion | 1.13576813 |
98 | MP0010352_gastrointestinal_tract_polyps | 1.13553315 |
99 | MP0005408_hypopigmentation | 1.13102641 |
100 | MP0008469_abnormal_protein_level | 1.13081710 |
101 | MP0001986_abnormal_taste_sensitivity | 1.12772729 |
102 | MP0000465_gastrointestinal_hemorrhage | 1.11799313 |
103 | MP0005397_hematopoietic_system_phenotyp | 1.11633665 |
104 | MP0001545_abnormal_hematopoietic_system | 1.11633665 |
105 | MP0008057_abnormal_DNA_replication | 1.11380467 |
106 | MP0000631_abnormal_neuroendocrine_gland | 1.09999022 |
107 | MP0008872_abnormal_physiological_respon | 1.09412619 |
108 | MP0002933_joint_inflammation | 1.08228139 |
109 | MP0003303_peritoneal_inflammation | 1.07241242 |
110 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05458530 |
111 | MP0002210_abnormal_sex_determination | 1.05160026 |
112 | MP0000516_abnormal_urinary_system | 1.04162365 |
113 | MP0005367_renal/urinary_system_phenotyp | 1.04162365 |
114 | MP0008007_abnormal_cellular_replicative | 1.03504927 |
115 | MP0002876_abnormal_thyroid_physiology | 1.03462012 |
116 | MP0002877_abnormal_melanocyte_morpholog | 1.02944022 |
117 | MP0005646_abnormal_pituitary_gland | 1.02494160 |
118 | MP0003172_abnormal_lysosome_physiology | 1.02061857 |
119 | MP0001764_abnormal_homeostasis | 1.00846810 |
120 | MP0009764_decreased_sensitivity_to | 1.00165776 |
121 | MP0008995_early_reproductive_senescence | 0.99522857 |
122 | MP0002090_abnormal_vision | 0.97562151 |
123 | MP0000049_abnormal_middle_ear | 0.97085579 |
124 | MP0005076_abnormal_cell_differentiation | 0.96979356 |
125 | MP0000015_abnormal_ear_pigmentation | 0.94151153 |
126 | MP0002009_preneoplasia | 0.92826313 |
127 | MP0001533_abnormal_skeleton_physiology | 0.91243850 |
128 | MP0010234_abnormal_vibrissa_follicle | 0.90448241 |
129 | MP0001919_abnormal_reproductive_system | 0.89562236 |
130 | MP0002837_dystrophic_cardiac_calcinosis | 0.87204136 |
131 | MP0002751_abnormal_autonomic_nervous | 0.86985026 |
132 | MP0000653_abnormal_sex_gland | 0.85797590 |
133 | MP0001145_abnormal_male_reproductive | 0.85369946 |
134 | MP0000383_abnormal_hair_follicle | 0.84763865 |
135 | MP0001119_abnormal_female_reproductive | 0.84705175 |
136 | MP0003646_muscle_fatigue | 0.83340813 |
137 | MP0006276_abnormal_autonomic_nervous | 0.82112927 |
138 | MP0003045_fibrosis | 0.80621673 |
139 | MP0002998_abnormal_bone_remodeling | 0.80465018 |
140 | MP0001324_abnormal_eye_pigmentation | 0.79265805 |
141 | MP0003787_abnormal_imprinting | 0.79226880 |
142 | MP0005670_abnormal_white_adipose | 0.79191553 |
143 | MP0005195_abnormal_posterior_eye | 0.77702838 |
144 | MP0004742_abnormal_vestibular_system | 0.76693191 |
145 | MP0005058_abnormal_lysosome_morphology | 0.76146275 |
146 | MP0001286_abnormal_eye_development | 0.75833017 |
147 | MP0009763_increased_sensitivity_to | 0.75616216 |
148 | MP0001851_eye_inflammation | 0.75427409 |
149 | MP0003315_abnormal_perineum_morphology | 0.75120336 |
150 | MP0003878_abnormal_ear_physiology | 0.74670148 |
151 | MP0005377_hearing/vestibular/ear_phenot | 0.74670148 |
152 | MP0000358_abnormal_cell_content/ | 0.74558582 |
153 | MP0004145_abnormal_muscle_electrophysio | 0.73987218 |
154 | MP0004381_abnormal_hair_follicle | 0.73851997 |
155 | MP0003183_abnormal_peptide_metabolism | 0.73437185 |
156 | MP0002282_abnormal_trachea_morphology | 0.69254600 |
157 | MP0000026_abnormal_inner_ear | 0.69097590 |
158 | MP0002928_abnormal_bile_duct | 0.68794497 |
159 | MP0005266_abnormal_metabolism | 0.67867078 |
160 | MP0003943_abnormal_hepatobiliary_system | 0.67568272 |
161 | MP0005391_vision/eye_phenotype | 0.67484094 |
162 | MP0002233_abnormal_nose_morphology | 0.67044993 |
163 | MP0008877_abnormal_DNA_methylation | 0.66984527 |
164 | MP0009765_abnormal_xenobiotic_induced | 0.66252206 |
165 | MP0002019_abnormal_tumor_incidence | 0.65897793 |
166 | MP0000249_abnormal_blood_vessel | 0.65462318 |
167 | MP0003638_abnormal_response/metabolism_ | 0.56366733 |
168 | MP0005174_abnormal_tail_pigmentation | 0.56088409 |
169 | MP0001216_abnormal_epidermal_layer | 0.54904647 |
170 | MP0001929_abnormal_gametogenesis | 0.53386100 |
171 | MP0010678_abnormal_skin_adnexa | 0.53132434 |
172 | MP0000477_abnormal_intestine_morphology | 0.49332326 |
173 | MP0003941_abnormal_skin_development | 0.49211588 |
174 | MP0002136_abnormal_kidney_physiology | 0.48863365 |
175 | MP0000371_diluted_coat_color | 0.48678704 |
176 | MP0000609_abnormal_liver_physiology | 0.47226502 |
177 | MP0000367_abnormal_coat/_hair | 0.45607393 |
178 | MP0005166_decreased_susceptibility_to | 0.44113191 |
179 | MP0009046_muscle_twitch | 0.43279441 |
180 | MP0005623_abnormal_meninges_morphology | 0.43199942 |
181 | MP0003795_abnormal_bone_structure | 0.42406121 |
182 | MP0008770_decreased_survivor_rate | 0.42156948 |
183 | MP0000598_abnormal_liver_morphology | 0.41952857 |
184 | MP0003453_abnormal_keratinocyte_physiol | 0.38345188 |
185 | MP0005023_abnormal_wound_healing | 0.37088196 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 8.07707121 |
2 | Increased cerebral lipofuscin (HP:0011813) | 7.25096108 |
3 | Loss of speech (HP:0002371) | 5.82813309 |
4 | Acute necrotizing encephalopathy (HP:0006965) | 5.37762368 |
5 | Nasal polyposis (HP:0100582) | 5.11708556 |
6 | Mitochondrial inheritance (HP:0001427) | 4.96079496 |
7 | Chronic otitis media (HP:0000389) | 4.92546393 |
8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.84334201 |
9 | Acute encephalopathy (HP:0006846) | 4.71400331 |
10 | Obstructive lung disease (HP:0006536) | 4.70083783 |
11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.70083783 |
12 | Recurrent bronchitis (HP:0002837) | 4.54271785 |
13 | Progressive macrocephaly (HP:0004481) | 4.49920865 |
14 | T lymphocytopenia (HP:0005403) | 4.48802564 |
15 | IgM deficiency (HP:0002850) | 4.46955215 |
16 | Increased CSF lactate (HP:0002490) | 4.33722601 |
17 | Abnormality of T cell number (HP:0011839) | 4.29551592 |
18 | Hepatocellular necrosis (HP:0001404) | 4.23561746 |
19 | Abnormality of the nasal mucosa (HP:0000433) | 4.19027978 |
20 | Increased hepatocellular lipid droplets (HP:0006565) | 4.05347910 |
21 | Abolished electroretinogram (ERG) (HP:0000550) | 4.03246322 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90660184 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90660184 |
24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90660184 |
25 | Hepatic necrosis (HP:0002605) | 3.88022441 |
26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.82992534 |
27 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.78301123 |
28 | Hemoptysis (HP:0002105) | 3.78035785 |
29 | 3-Methylglutaconic aciduria (HP:0003535) | 3.76793194 |
30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71080546 |
31 | Acrocyanosis (HP:0001063) | 3.64644821 |
32 | Myositis (HP:0100614) | 3.63136560 |
33 | Optic neuritis (HP:0100653) | 3.62867675 |
34 | Retrobulbar optic neuritis (HP:0100654) | 3.62867675 |
35 | Cerebral palsy (HP:0100021) | 3.60947203 |
36 | Vasculitis (HP:0002633) | 3.57468878 |
37 | Renal Fanconi syndrome (HP:0001994) | 3.53812975 |
38 | Testicular atrophy (HP:0000029) | 3.49601546 |
39 | Abnormal number of erythroid precursors (HP:0012131) | 3.46933924 |
40 | Recurrent sinusitis (HP:0011108) | 3.44577429 |
41 | IgG deficiency (HP:0004315) | 3.41842215 |
42 | Reticulocytopenia (HP:0001896) | 3.39296058 |
43 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.37631640 |
44 | Abnormality of the pleura (HP:0002103) | 3.36487149 |
45 | Pancreatic cysts (HP:0001737) | 3.36361037 |
46 | Recurrent abscess formation (HP:0002722) | 3.30666639 |
47 | Cerebral edema (HP:0002181) | 3.28445414 |
48 | Autoimmune hemolytic anemia (HP:0001890) | 3.25276470 |
49 | Meningitis (HP:0001287) | 3.24253676 |
50 | Eczematoid dermatitis (HP:0000976) | 3.20490464 |
51 | Recurrent viral infections (HP:0004429) | 3.19816531 |
52 | Molar tooth sign on MRI (HP:0002419) | 3.16585113 |
53 | Abnormality of midbrain morphology (HP:0002418) | 3.16585113 |
54 | Recurrent fungal infections (HP:0002841) | 3.14894505 |
55 | Abnormality of T cells (HP:0002843) | 3.13465032 |
56 | Pancreatic fibrosis (HP:0100732) | 3.12308802 |
57 | Orchitis (HP:0100796) | 3.09152437 |
58 | Bronchitis (HP:0012387) | 3.05821168 |
59 | Pulmonary infiltrates (HP:0002113) | 3.04492469 |
60 | True hermaphroditism (HP:0010459) | 3.00338264 |
61 | Macular degeneration (HP:0000608) | 2.99441073 |
62 | Stomatitis (HP:0010280) | 2.95410830 |
63 | Combined immunodeficiency (HP:0005387) | 2.95320254 |
64 | Abnormality of the pericardium (HP:0001697) | 2.92888687 |
65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.91810524 |
66 | Exertional dyspnea (HP:0002875) | 2.89416261 |
67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.89234774 |
68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.88962585 |
69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.88962585 |
70 | Lactic acidosis (HP:0003128) | 2.87431171 |
71 | Severe combined immunodeficiency (HP:0004430) | 2.85324640 |
72 | Congenital, generalized hypertrichosis (HP:0004540) | 2.83454243 |
73 | Macrocytic anemia (HP:0001972) | 2.81800707 |
74 | Increased serum lactate (HP:0002151) | 2.79588126 |
75 | Abnormality of eosinophils (HP:0001879) | 2.76713477 |
76 | Optic disc pallor (HP:0000543) | 2.74325225 |
77 | Type I transferrin isoform profile (HP:0003642) | 2.71806069 |
78 | IgA deficiency (HP:0002720) | 2.68810460 |
79 | Arterial thrombosis (HP:0004420) | 2.68767182 |
80 | Abnormality of the fingertips (HP:0001211) | 2.66972262 |
81 | Progressive microcephaly (HP:0000253) | 2.66072068 |
82 | Respiratory failure (HP:0002878) | 2.65845428 |
83 | Emphysema (HP:0002097) | 2.64335023 |
84 | Glomerulopathy (HP:0100820) | 2.60357255 |
85 | Recurrent bacterial skin infections (HP:0005406) | 2.59039047 |
86 | Abnormality of the prostate (HP:0008775) | 2.59003306 |
87 | Abnormal platelet volume (HP:0011876) | 2.58759700 |
88 | Pulmonary fibrosis (HP:0002206) | 2.56898380 |
89 | Aplastic anemia (HP:0001915) | 2.56565498 |
90 | Absent thumb (HP:0009777) | 2.53393258 |
91 | Azoospermia (HP:0000027) | 2.52530505 |
92 | Keratoconjunctivitis sicca (HP:0001097) | 2.50646837 |
93 | Chronic sinusitis (HP:0011109) | 2.49397928 |
94 | Joint swelling (HP:0001386) | 2.47389729 |
95 | Lymphoma (HP:0002665) | 2.46550848 |
96 | Bronchiectasis (HP:0002110) | 2.44357130 |
97 | Exercise intolerance (HP:0003546) | 2.42555840 |
98 | Chronic diarrhea (HP:0002028) | 2.42178563 |
99 | Pustule (HP:0200039) | 2.42115263 |
100 | Anorexia (HP:0002039) | 2.42081534 |
101 | Increased mean platelet volume (HP:0011877) | 2.41953819 |
102 | Abnormal spermatogenesis (HP:0008669) | 2.41936617 |
103 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.41891611 |
104 | Increased muscle lipid content (HP:0009058) | 2.41822818 |
105 | Methylmalonic acidemia (HP:0002912) | 2.41441478 |
106 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.40043075 |
107 | Recurrent otitis media (HP:0000403) | 2.39565789 |
108 | Lymphopenia (HP:0001888) | 2.39003217 |
109 | Eosinophilia (HP:0001880) | 2.38057248 |
110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.38008949 |
111 | Abnormal protein glycosylation (HP:0012346) | 2.37383666 |
112 | Abnormal glycosylation (HP:0012345) | 2.37383666 |
113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37383666 |
114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37383666 |
115 | Gingival bleeding (HP:0000225) | 2.36030626 |
116 | Thyroiditis (HP:0100646) | 2.35058260 |
117 | Gastrointestinal infarctions (HP:0005244) | 2.34655739 |
118 | Leukodystrophy (HP:0002415) | 2.34527943 |
119 | Respiratory difficulties (HP:0002880) | 2.34444813 |
120 | Increased IgE level (HP:0003212) | 2.34033287 |
121 | Petechiae (HP:0000967) | 2.33938465 |
122 | Meckel diverticulum (HP:0002245) | 2.33015403 |
123 | Skin rash (HP:0000988) | 2.31854238 |
124 | Mediastinal lymphadenopathy (HP:0100721) | 2.29828741 |
125 | Abnormality of the ileum (HP:0001549) | 2.27196951 |
126 | Abnormality of complement system (HP:0005339) | 2.26937355 |
127 | Restrictive lung disease (HP:0002091) | 2.25962679 |
128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25879558 |
129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25629532 |
130 | Abnormality of alanine metabolism (HP:0010916) | 2.25629532 |
131 | Hyperalaninemia (HP:0003348) | 2.25629532 |
132 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25455192 |
133 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25455192 |
134 | Methylmalonic aciduria (HP:0012120) | 2.25282408 |
135 | Abnormality of renal resorption (HP:0011038) | 2.24975746 |
136 | Medial flaring of the eyebrow (HP:0010747) | 2.24369757 |
137 | Encephalitis (HP:0002383) | 2.23672750 |
138 | Sclerocornea (HP:0000647) | 2.21600881 |
139 | Keratoconjunctivitis (HP:0001096) | 2.21437248 |
140 | Poor head control (HP:0002421) | 2.20325036 |
141 | Increased IgM level (HP:0003496) | 2.20254033 |
142 | Leukocytosis (HP:0001974) | 2.18017886 |
143 | Colon cancer (HP:0003003) | 2.18001662 |
144 | Gangrene (HP:0100758) | 2.13570315 |
145 | Lethargy (HP:0001254) | 2.13478436 |
146 | Progressive visual loss (HP:0000529) | 2.13346446 |
147 | Congenital stationary night blindness (HP:0007642) | 2.13133978 |
148 | Nephronophthisis (HP:0000090) | 2.12809247 |
149 | Thrombocytosis (HP:0001894) | 2.12012221 |
150 | Trigonocephaly (HP:0000243) | 2.09734763 |
151 | Pulmonary embolism (HP:0002204) | 2.09228517 |
152 | Prolonged bleeding time (HP:0003010) | 2.05172925 |
153 | Granulocytopenia (HP:0001913) | 2.04218277 |
154 | Abnormality of B cell number (HP:0010975) | 2.03921538 |
155 | B lymphocytopenia (HP:0010976) | 2.03921538 |
156 | Glycosuria (HP:0003076) | 2.03715945 |
157 | Abnormality of urine glucose concentration (HP:0011016) | 2.03715945 |
158 | Inflammation of the large intestine (HP:0002037) | 2.03226120 |
159 | CNS demyelination (HP:0007305) | 2.03050677 |
160 | Polyneuropathy (HP:0001271) | 2.02554688 |
161 | Recurrent skin infections (HP:0001581) | 2.02328527 |
162 | Pancytopenia (HP:0001876) | 2.01452799 |
163 | Generalized aminoaciduria (HP:0002909) | 2.00448009 |
164 | Pallor (HP:0000980) | 1.99327725 |
165 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.98068701 |
166 | Septo-optic dysplasia (HP:0100842) | 1.93854131 |
167 | Reduced antithrombin III activity (HP:0001976) | 1.92992749 |
168 | Triphalangeal thumb (HP:0001199) | 1.91094400 |
169 | Male pseudohermaphroditism (HP:0000037) | 1.90636027 |
170 | Oral leukoplakia (HP:0002745) | 1.89086548 |
171 | Abnormality of chromosome stability (HP:0003220) | 1.88452094 |
172 | Abnormality of the preputium (HP:0100587) | 1.87785954 |
173 | Pendular nystagmus (HP:0012043) | 1.87417505 |
174 | Renal cortical cysts (HP:0000803) | 1.85567427 |
175 | Bile duct proliferation (HP:0001408) | 1.83517188 |
176 | Abnormal biliary tract physiology (HP:0012439) | 1.83517188 |
177 | Abnormality of the pons (HP:0007361) | 1.81051897 |
178 | Type II lissencephaly (HP:0007260) | 1.80341330 |
179 | Anencephaly (HP:0002323) | 1.77602799 |
180 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.76447134 |
181 | Stenosis of the external auditory canal (HP:0000402) | 1.75947049 |
182 | Abnormality of the renal cortex (HP:0011035) | 1.75158625 |
183 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.74628481 |
184 | Cleft eyelid (HP:0000625) | 1.71994740 |
185 | X-linked dominant inheritance (HP:0001423) | 1.70853208 |
186 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70794275 |
187 | Abnormality of the renal medulla (HP:0100957) | 1.70090262 |
188 | Hypoplasia of the pons (HP:0012110) | 1.69860627 |
189 | Hyperglycinemia (HP:0002154) | 1.68347795 |
190 | Congenital primary aphakia (HP:0007707) | 1.66492865 |
191 | Small intestinal stenosis (HP:0012848) | 1.66333750 |
192 | Duodenal stenosis (HP:0100867) | 1.66333750 |
193 | Abnormality of serum amino acid levels (HP:0003112) | 1.62463724 |
194 | Dicarboxylic aciduria (HP:0003215) | 1.61371219 |
195 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.61371219 |
196 | Postaxial foot polydactyly (HP:0001830) | 1.58533714 |
197 | Blindness (HP:0000618) | 1.58209459 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 7.63351303 |
2 | TXK | 6.21634533 |
3 | VRK2 | 4.87325969 |
4 | ITK | 3.83159127 |
5 | ZAK | 3.62204011 |
6 | BUB1 | 3.03591633 |
7 | TYK2 | 2.88851775 |
8 | STK16 | 2.78987624 |
9 | FGFR4 | 2.77968854 |
10 | KIT | 2.73406686 |
11 | MAP3K12 | 2.61601028 |
12 | JAK1 | 2.32492538 |
13 | ZAP70 | 2.31610622 |
14 | MAP4K2 | 2.21928650 |
15 | TLK1 | 2.20436978 |
16 | STK10 | 2.05894349 |
17 | SYK | 2.05005413 |
18 | BMPR1B | 2.04704592 |
19 | FGFR3 | 2.01712547 |
20 | WNK3 | 2.00428172 |
21 | CDC7 | 2.00161533 |
22 | JAK3 | 1.99675934 |
23 | TBK1 | 1.98289278 |
24 | CSF1R | 1.97338870 |
25 | IKBKE | 1.93118427 |
26 | ADRBK2 | 1.91667683 |
27 | NEK1 | 1.85032552 |
28 | MAP3K14 | 1.81648891 |
29 | IRAK4 | 1.73664879 |
30 | WEE1 | 1.71924931 |
31 | EIF2AK3 | 1.68351301 |
32 | BCKDK | 1.65266985 |
33 | PLK4 | 1.63546779 |
34 | CSK | 1.62014335 |
35 | SRPK1 | 1.53726150 |
36 | EEF2K | 1.53435358 |
37 | TEC | 1.51874147 |
38 | TRIM28 | 1.51503327 |
39 | LCK | 1.48472373 |
40 | PLK3 | 1.47604939 |
41 | NUAK1 | 1.45489339 |
42 | NME1 | 1.44203266 |
43 | TSSK6 | 1.42815831 |
44 | PBK | 1.35834334 |
45 | TAF1 | 1.33648345 |
46 | DYRK2 | 1.29641703 |
47 | PRKCQ | 1.29062422 |
48 | IKBKB | 1.28568173 |
49 | INSRR | 1.27532623 |
50 | MST4 | 1.26648827 |
51 | HCK | 1.25920096 |
52 | TAOK3 | 1.25568766 |
53 | LYN | 1.20824148 |
54 | BLK | 1.10308288 |
55 | MUSK | 1.05398437 |
56 | CCNB1 | 1.05367063 |
57 | CHEK2 | 1.00828629 |
58 | BTK | 1.00743807 |
59 | PIM1 | 1.00050018 |
60 | BRSK2 | 0.98711174 |
61 | CSNK1G3 | 0.98278535 |
62 | GRK6 | 0.95701614 |
63 | PLK1 | 0.95627741 |
64 | GRK1 | 0.95356362 |
65 | TTK | 0.95154384 |
66 | MKNK2 | 0.92924470 |
67 | MKNK1 | 0.90216593 |
68 | CDK8 | 0.89875568 |
69 | PDK1 | 0.88848217 |
70 | CSNK1G2 | 0.86658214 |
71 | OXSR1 | 0.86105570 |
72 | MARK3 | 0.84132881 |
73 | ATR | 0.83520471 |
74 | RPS6KA5 | 0.82764746 |
75 | STK24 | 0.81554084 |
76 | EPHB1 | 0.81342862 |
77 | JAK2 | 0.80467355 |
78 | NLK | 0.79330174 |
79 | MAP2K6 | 0.78342842 |
80 | TRPM7 | 0.78042289 |
81 | PINK1 | 0.77665822 |
82 | TAOK2 | 0.77185964 |
83 | EIF2AK2 | 0.76835704 |
84 | ACVR1B | 0.76763003 |
85 | LRRK2 | 0.75581513 |
86 | AURKB | 0.72497990 |
87 | TGFBR2 | 0.71791078 |
88 | ERBB3 | 0.71633695 |
89 | MAPK13 | 0.70879757 |
90 | DYRK3 | 0.70869066 |
91 | PDK3 | 0.70416388 |
92 | PDK4 | 0.70416388 |
93 | MAPK15 | 0.69986973 |
94 | GRK7 | 0.69521105 |
95 | PRKCH | 0.68970307 |
96 | MYLK | 0.68946733 |
97 | CSNK1A1L | 0.67475820 |
98 | FLT3 | 0.67167524 |
99 | TNIK | 0.66346750 |
100 | ABL2 | 0.64863960 |
101 | NEK2 | 0.63846212 |
102 | NEK9 | 0.63249323 |
103 | TESK2 | 0.61760681 |
104 | CSNK2A1 | 0.61483194 |
105 | FGFR2 | 0.61259158 |
106 | CAMKK2 | 0.61216836 |
107 | PLK2 | 0.60518435 |
108 | LIMK1 | 0.60174509 |
109 | MAP2K7 | 0.57586161 |
110 | MAP3K4 | 0.55987388 |
111 | TESK1 | 0.54194974 |
112 | KDR | 0.53460925 |
113 | MELK | 0.53129787 |
114 | ADRBK1 | 0.52784772 |
115 | IRAK3 | 0.52603069 |
116 | MAPK11 | 0.52057189 |
117 | STK3 | 0.51775420 |
118 | GRK5 | 0.51511524 |
119 | CDK12 | 0.50298874 |
120 | DAPK3 | 0.49935872 |
121 | AURKA | 0.49495864 |
122 | CSNK2A2 | 0.48830922 |
123 | CHUK | 0.47844112 |
124 | FES | 0.47632621 |
125 | CDK3 | 0.47582226 |
126 | EIF2AK1 | 0.47412123 |
127 | PRKCG | 0.46463225 |
128 | CLK1 | 0.45462243 |
129 | PIK3CG | 0.45388205 |
130 | BRSK1 | 0.45111415 |
131 | PRKCD | 0.43689526 |
132 | RPS6KB2 | 0.42757220 |
133 | MATK | 0.42211704 |
134 | TIE1 | 0.42127354 |
135 | CDK4 | 0.41918335 |
136 | PNCK | 0.41197276 |
137 | DYRK1B | 0.39471011 |
138 | MAPKAPK2 | 0.39152611 |
139 | RPS6KA4 | 0.38270258 |
140 | PRKD2 | 0.38023791 |
141 | STK11 | 0.37872627 |
142 | IGF1R | 0.37704427 |
143 | TGFBR1 | 0.37484302 |
144 | PASK | 0.37292344 |
145 | CSNK1A1 | 0.35226480 |
146 | WNK4 | 0.35179843 |
147 | STK39 | 0.34237536 |
148 | SCYL2 | 0.33379548 |
149 | PRKCE | 0.33185128 |
150 | MAP3K8 | 0.32789524 |
151 | CDK6 | 0.32598864 |
152 | EPHA3 | 0.32554917 |
153 | CSNK1G1 | 0.31041807 |
154 | OBSCN | 0.30344142 |
155 | BCR | 0.29926642 |
156 | NTRK2 | 0.28667252 |
157 | PDK2 | 0.27983782 |
158 | FYN | 0.26829532 |
159 | MAPKAPK5 | 0.26824947 |
160 | MAP3K7 | 0.26061970 |
161 | ALK | 0.24968885 |
162 | SIK3 | 0.24919799 |
163 | CDK19 | 0.24353913 |
164 | TAOK1 | 0.24238803 |
165 | RIPK4 | 0.22030955 |
166 | MAP3K5 | 0.20806855 |
167 | MAPK7 | 0.20269251 |
168 | TNK2 | 0.19904084 |
169 | NME2 | 0.19423694 |
170 | PAK4 | 0.19366305 |
171 | INSR | 0.17388191 |
172 | MAP3K13 | 0.17349839 |
173 | STK4 | 0.16802017 |
174 | VRK1 | 0.15888741 |
175 | MAPK3 | 0.15578600 |
176 | FRK | 0.15352609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.63572050 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.50334731 |
3 | Ribosome_Homo sapiens_hsa03010 | 4.29089775 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.81293082 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70482756 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.41113246 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.37570026 |
8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.27247797 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 3.21635885 |
10 | Protein export_Homo sapiens_hsa03060 | 2.95653980 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.89598909 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.84062068 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.78928466 |
14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.73181454 |
15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.61952827 |
16 | Measles_Homo sapiens_hsa05162 | 2.60086826 |
17 | Mismatch repair_Homo sapiens_hsa03430 | 2.55185286 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 2.52551674 |
19 | Alzheimers disease_Homo sapiens_hsa05010 | 2.51092464 |
20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.34129109 |
21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.26704942 |
22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96341840 |
23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.95427057 |
24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91497086 |
25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88505913 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87514196 |
27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84586882 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84327556 |
29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.82221150 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77185802 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76873117 |
32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75408454 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.71777341 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70573075 |
35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69854939 |
36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.65705815 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64976632 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64762544 |
39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57954812 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56771243 |
41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49554611 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.48884848 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45325303 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42487899 |
45 | Lysosome_Homo sapiens_hsa04142 | 1.42473135 |
46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42344782 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41938150 |
48 | Shigellosis_Homo sapiens_hsa05131 | 1.40837605 |
49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33336699 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28830954 |
51 | Purine metabolism_Homo sapiens_hsa00230 | 1.27815898 |
52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24712200 |
53 | Platelet activation_Homo sapiens_hsa04611 | 1.21647997 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 1.20030346 |
55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.17887770 |
56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.15470260 |
57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13951825 |
58 | Hepatitis B_Homo sapiens_hsa05161 | 1.11075421 |
59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10503694 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08252397 |
61 | RNA transport_Homo sapiens_hsa03013 | 1.08210657 |
62 | Legionellosis_Homo sapiens_hsa05134 | 1.02480082 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02472438 |
64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01738542 |
65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00091266 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.99638574 |
67 | Phototransduction_Homo sapiens_hsa04744 | 0.99053101 |
68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98960307 |
69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98637499 |
70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96676909 |
71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95507914 |
72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95406957 |
73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94807233 |
74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93082453 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89704734 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87700926 |
77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86739187 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.86720516 |
79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85132995 |
80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82661136 |
81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82366223 |
82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81665403 |
83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80396477 |
84 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79357869 |
85 | Peroxisome_Homo sapiens_hsa04146 | 0.79094697 |
86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78986421 |
87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78571685 |
88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77320302 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75957287 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75866440 |
91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75615518 |
92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74829008 |
93 | Malaria_Homo sapiens_hsa05144 | 0.74052633 |
94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71402939 |
95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71272018 |
96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71248592 |
97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70856204 |
98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69261546 |
99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69259840 |
100 | Hepatitis C_Homo sapiens_hsa05160 | 0.68332201 |
101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67760585 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67495104 |
103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64857048 |
104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64705949 |
105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61506292 |
106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60838318 |
107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60030410 |
108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59265058 |
109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58977595 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58899017 |
111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58300162 |
112 | Endocytosis_Homo sapiens_hsa04144 | 0.58247996 |
113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58107901 |
114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56039620 |
115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55452179 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54124656 |
117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52355219 |
118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51298556 |
119 | DNA replication_Homo sapiens_hsa03030 | 0.51156378 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46753383 |
121 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46225353 |
122 | Adherens junction_Homo sapiens_hsa04520 | 0.45035012 |
123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44648335 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44391259 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42673716 |
126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42327575 |
127 | Pertussis_Homo sapiens_hsa05133 | 0.39241787 |
128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38674568 |
129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38348652 |
130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37295559 |
131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36175080 |
132 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36012606 |
133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35865839 |
134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34477451 |
135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33665392 |
136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33620864 |
137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32961760 |
138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32757138 |
139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32693692 |
140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32332155 |
141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31587675 |
142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31258690 |
143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30972851 |
144 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30640208 |
145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.29944676 |
146 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29359915 |
147 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28506523 |
148 | ABC transporters_Homo sapiens_hsa02010 | 0.28280850 |
149 | Asthma_Homo sapiens_hsa05310 | 0.28210324 |
150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28057785 |
151 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26789454 |
152 | Spliceosome_Homo sapiens_hsa03040 | 0.26523222 |
153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26141515 |
154 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26113867 |
155 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25795460 |
156 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25667691 |
157 | Proteasome_Homo sapiens_hsa03050 | 0.25554906 |
158 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23146133 |
159 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.21742953 |
160 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.21495759 |
161 | Alcoholism_Homo sapiens_hsa05034 | 0.20866195 |
162 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20175220 |
163 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18266890 |
164 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17883689 |
165 | Basal transcription factors_Homo sapiens_hsa03022 | 0.16771496 |
166 | Base excision repair_Homo sapiens_hsa03410 | 0.15640119 |
167 | Cell cycle_Homo sapiens_hsa04110 | 0.15365696 |
168 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13928892 |
169 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.12370387 |
170 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11830395 |
171 | Mineral absorption_Homo sapiens_hsa04978 | 0.09321535 |
172 | RNA degradation_Homo sapiens_hsa03018 | 0.08475316 |
173 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07941846 |